For a molecule that almost nobody had heard of in 2015, NAD+ has reached an unusual level of mainstream wellness visibility. Long-form podcasts, biohacker communities, longevity-focused publications, and increasingly mainstream wellness coverage have all converged on the same underlying story: NAD+ is a compound the body uses constantly, levels decline with age, and supplementation strategies have moved from theoretical to widely available.

The science is real, the supplementation case is at least partly grounded, and the gap between laboratory pharmacology and consumer-product reality is meaningful enough to warrant a careful look.

What NAD+ actually is

NAD+, or nicotinamide adenine dinucleotide, is a coenzyme found in every cell of the human body. It plays roles in energy metabolism, DNA repair, gene expression, and cellular response to stress. NAD+ levels in tissues decline with age, and the decline correlates with a range of age-related cellular changes documented across thousands of peer-reviewed studies indexed on the U.S. National Library of Medicine’s PubMed platform.

The decline pattern has driven interest in interventions that raise NAD+ levels, either by providing precursor molecules the body uses to synthesise NAD+ or by inhibiting the enzymes that consume it.

Precursor supplementation and what it involves

Two NAD+ precursors dominate the consumer market. Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) both raise NAD+ levels in cells when administered, with documented increases in blood and tissue measurements in published clinical trials.

NAD+ capsules typically deliver one of these precursors, with the most-studied form being NR commercially marketed as Niagen. The supplementation pathway has been examined in randomised trials at multiple universities, with documented increases in circulating NAD+ levels and favourable safety profiles in adult populations.

Where the evidence base is strong and where it is incomplete

Strong evidence: NAD+ precursor supplementation does raise circulating NAD+ levels in adult humans. The biochemistry is established.

Reasonable evidence: Specific clinical applications including support for muscle function in older adults, cardiovascular markers, and metabolic markers have shown favourable but not definitive results in published trials.

Weaker evidence: The broader anti-aging and longevity claims that dominate consumer marketing remain hypothesis-generating rather than rigorously established. Population-level mortality benefits have not been demonstrated.

The honest framing is that NAD+ supplementation is a plausible intervention with a reasonable safety profile and evolving evidence. It is not a proven longevity intervention by current clinical standards.

FAQ

Is NAD+ supplementation safe? Adult supplementation studies have shown favourable safety profiles. Specific medical conditions warrant clinical consultation.

What is the difference between NR and NMN? Both are NAD+ precursors. NR has more published clinical research. NMN has comparable mechanistic data but less long-term human trial coverage.

Should I take NAD+ daily? Daily dosing is the standard supplementation pattern in published studies.

Will NAD+ make me live longer? The clinical literature does not currently support this claim. The cellular biochemistry is real; the mortality benefit is not established.